Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance
Flexible, scalable sales teams for rapid product launch

& lifecycle management
Real-time insights
powered by a one-of-a-kind comprehensive qualitative database — AnswerY

Premium content & audience access to critical oncology care networks

Continuous growth for teams and individuals led by pharma industry experts

Medical Affairs Nephrology

MSLs Change Provider Behavior

Download PDF
Prepare the market for a new indication of a mature product by adding medical science liaisons to a client’s existing team.
OUR TASK
Help launch a new indication for a mature immunology product, in an area where our partner’s MSLs lack relationships and therapeutic expertise. Look to us to help the scientific community understand the new indication. Within 6 months, we engaged 1,000+ thought leaders and exceeded monthly KOL touchpoints by 14%. Analysis showed a measurable change in clinical practice.
Download PDF

The Power of This Partnership

87%

HCPs Change Behavior

14%

Outperformance vs. Expected # of KOL Engagements

1000+

KOL Engagements in 6 Months

The Ask
CLIENT
Global
Large BioPharma
Medical affairs professionals conduct scientific engagement with key opinion leaders.
Find Experienced MSLs
Bring on board a team with deep therapeutic knowledge and known relationships with KOLs.
Create Understanding
Conduct scientific exchange with nephrologists and HCPs who treat patients with kidney disease.
Elevate + Upskill Client Team Members
Lead the effort to upskill the client’s team, share knowledge and best practices, + develop internal working groups so that internal and external MSLs excel.
The Approach
TOOLS
Medical Science Liaison
AnswerY
Amplity MSLs share their knowledge of kidney disease with client’s MSLs, who were trained on another indication.
Hire Good People
Quickly build a team of nephrology-experienced MSLs who can talk to HCPs who treat patients with kidney disease.
Get Access
Within six months, conduct scientific exchange with 1000+ KOLs and nephrology researchers at Centers of Excellence nationwide.
Train the Internal Team + Measure Impact
Through ongoing internal working groups led by Amplity’s MSLs, client MSLs are upskilled in the new therapeutic area.
The Results
OUTCOME
Business Objectives Exceeded
Client Satisfaction
HCP Behavior Change
Measurable Behavior Change
The frequency of biomarker mentions by KOLs increased significantly after Amplity MSLs spoke with them, quantifying the impact of MSLs at the point-of-care. Analysis showed 87% of KOLs changed their practice patterns around patient diagnosis.
Improved KOL Engagement
Both Amplity and internal teams exceeded monthly KPIs for provider interactions by 14%, showing the power of augmenting teams with external experts.
Client Satisfaction
Client was thrilled and Amplity was tasked with pre-launch preparation for the client’s next nephrology product.

Read Next

Read More arrow